Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Materials

Fillable polymer microparticles offer a new means for delivering vaccines

Injected microparticles release contents at preprogrammed dosage times on the basis of polymer composition

by Celia Henry Arnaud
September 18, 2017 | A version of this story appeared in Volume 95, Issue 37

[+]Enlarge
Credit: Science
An indivdiual fabricated microparticle before it's been filled and sealed (top) and an array of sealed microparticles.
Scanning electron micrographs of an individual particle and an array of particles.
Credit: Science
An indivdiual fabricated microparticle before it's been filled and sealed (top) and an array of sealed microparticles.

Three-dimensional printing is a powerful technique for rapid prototyping, but when put into practical use, the approach may not be compatible with materials used for biomedical applications such as drug delivery. Robert S. Langer, Ana Jaklenec, and coworkers at Massachusetts Institute of Technology have developed an alternative method for making microdevices from biomedically relevant materials, such as poly(lactic-co-glycolic acid) (Science 2017, DOI: 10.1126/science.aaf7447). The researchers use polydimethylsiloxane molds to shape individual layers of multilayer polymeric devices. They then align, assemble, and bond the layers using heat. The MIT team used the method to make fillable polymer microparticles that release their contents according to a preprogrammed schedule on the basis of polymer composition. They built particle bases, filled them with drug solution, capped the bases with polymer lids, sealed them by heating, and then scraped the microparticles off the substrate. In a test application, the researchers made single-injection vaccines by placing antigen doses in microparticles that release the contents at desired intervals. They gave mice a single injection of a mixture of microparticles that released ovalbumin, a model antigen, nine and 41 days after injection. Those mice achieved antibody levels higher than those in mice given separate ovalbumin injections at days six and 36. In addition to drug delivery applications, the MIT researchers used the fabrication method to make a pH sensor and microfluidic devices.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.